Expression of the PIM2 gene is associated with more aggressive clinical course in patients with chronic lymphocytic leukemiaKatarzyna Kapelko‐Słowik(Wroclaw Medical University), Dariusz Wołowiec(Medical University of Warsaw)Advances in Clinical and Experimental MedicineDecember 7, 201810.17219/acem/90771Cited by 5SaveCiteExport RISWatch citationsRelated PapersPrognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy|Cancers|2023|3